Extracellular matrix regulation of myelination
髓鞘形成的细胞外基质调节
基本信息
- 批准号:7755370
- 负责人:
- 金额:$ 36.88万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2006
- 资助国家:美国
- 起止时间:2006-08-02 至 2012-10-31
- 项目状态:已结题
- 来源:
- 关键词:Alzheimer&aposs DiseaseAutistic DisorderBinding SitesBiological ModelsBlocking AntibodiesBrainCellsCoculture TechniquesDemyelinating DiseasesDevelopmentDiseaseDystroglycanEngineeringEnvironmentEventExtracellular MatrixGoalsHollyIndividualIntegrinsLamininLaminin ReceptorLeadLearningMediatingModelingMolecularMonitorMultiple SclerosisMusMutateMyelinNerve DegenerationNeurodegenerative DisordersNeuronsOligodendrogliaPhenotypePhosphotransferasesPlayProcessReceptor SignalingRegulationResearchResearch DesignResearch PersonnelRoleSchizophreniaSignal TransductionSignaling MoleculeSystemTestingbrain cellcomputerized data processingdesignin vivomyelinationprogramsprotein-tyrosine kinase c-srcreceptorreceptor bindingresearch studysmall hairpin RNA
项目摘要
Myelination is essential for brain development and function but the precise mechanisms that control the
development of myelinating oligodendrocytes are not known. In demyelinating diseases such as multiple
sclerosis, the loss of myelin is also thought to contribute to neurodegeneration. Myelin abnormalities of
unknown origin are also found in autism, schizophrenia, and Alzheimer's disease. Candidates to regulate
myelination include extrinsic factors such as extracellular matrix (ECM) molecules found in the developing
brain. In contrast to neurons, little is known about the oligodendrocyte receptors and signaling mechanisms
that regulate interactions with ECM. The long term goal of our research is to understand to what degree
ECM regulates myelination and to determine how ECM signals lead to phenotypic changes in myelinating
cells. In the current proposal we will test the hypothesis that the ECM molecule laminin enhances the
survival and differentiation of oligodendrocytes by acting through specific transmembrane receptors and
signaling effector molecules. We will first determine the oligodendrocyte receptor requirements for laminins
using several approaches to disrupt or addback individual receptor interactions in oligodendrocytes alone or
in coculture with neurons. Fyn kinase is required for laminin to enhance oligodendrocyte survival and
differentiation, but the molecular mechanisms underlying this requirement are not known. We will test the
hypothesis that laminins modulate Fyn regulatory mechanisms using experiments designed to disrupt Fyn
regulatory molecules as well as to monitor Fyn regulatory mechansims that are activated by laminins. Finally,
we will test whether Fyn regulatory mechanisms are modulated by laminins in vivo using a model for laminin
deficiency that causes CMSdysmyelination. These studies are designed to uncover key mechanisms in the
reciprocal axonal-glial signaling events that trigger and regulate the processes of oligodendrocyte survival,
differentiation, and myelination.
We hope to discover signals that stimulate myelination, a process where specialized brain cells produce
an insulation, termed myelin, that is necessary for the survival and function of neurons. In doing so, we may
learn which of these signals are missing or scrambled in diseases such as Multiple Sclerosis where myelin is
destroyed, and, may learn how to protect neurons in neurodegenerative diseases such as Alzheimer's.
髓鞘形成对于大脑发育和功能至关重要,但控制髓鞘形成的精确机制
髓鞘少突胶质细胞的发育尚不清楚。在多发性脱髓鞘疾病中
硬化症、髓鞘质丧失也被认为会导致神经退行性变。髓磷脂异常
自闭症、精神分裂症和阿尔茨海默病中也发现了不明原因。监管候选人
髓鞘形成包括外在因素,例如发育中的细胞外基质(ECM)分子
脑。与神经元相反,人们对少突胶质细胞受体和信号传导机制知之甚少
调节与 ECM 的相互作用。我们研究的长期目标是了解到什么程度
ECM 调节髓鞘形成并确定 ECM 信号如何导致髓鞘形成的表型变化
细胞。在当前的提案中,我们将测试 ECM 分子层粘连蛋白增强的假设
通过特定跨膜受体的作用来促进少突胶质细胞的存活和分化
信号传导效应分子。我们首先确定少突胶质细胞受体对层粘连蛋白的要求
使用多种方法单独破坏或添加少突胶质细胞中的个体受体相互作用,或
与神经元共培养。层粘连蛋白需要 Fyn 激酶来增强少突胶质细胞的存活和
分化,但这种要求背后的分子机制尚不清楚。我们将测试
假设层粘连蛋白通过旨在破坏 Fyn 的实验来调节 Fyn 调节机制
调节分子以及监测由层粘连蛋白激活的 Fyn 调节机制。最后,
我们将使用层粘连蛋白模型来测试 Fyn 调节机制是否在体内受到层粘连蛋白的调节
导致 CMS 髓鞘发育不良的缺陷。这些研究旨在揭示关键机制
触发和调节少突胶质细胞存活过程的相互轴突-神经胶质信号传导事件,
分化和髓鞘形成。
我们希望发现刺激髓鞘形成的信号,髓鞘形成是专门的脑细胞产生的过程
一种称为髓磷脂的绝缘体,对于神经元的生存和功能是必需的。这样做时,我们可以
了解在多发性硬化症等髓鞘质缺失的疾病中,哪些信号缺失或混乱
被破坏,并且可能会学习如何保护阿尔茨海默氏症等神经退行性疾病中的神经元。
项目成果
期刊论文数量(9)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Dystroglycan Suppresses Notch to Regulate Stem Cell Niche Structure and Function in the Developing Postnatal Subventricular Zone.
- DOI:10.1016/j.devcel.2016.07.017
- 发表时间:2016-09-12
- 期刊:
- 影响因子:11.8
- 作者:McClenahan FK;Sharma H;Shan X;Eyermann C;Colognato H
- 通讯作者:Colognato H
Tyrosine phosphatases Shp1 and Shp2 have unique and opposing roles in oligodendrocyte development.
- DOI:10.1111/j.1471-4159.2010.06596.x
- 发表时间:2010-04
- 期刊:
- 影响因子:4.7
- 作者:Kuo E;Park DK;Tzvetanova ID;Leiton CV;Cho BS;Colognato H
- 通讯作者:Colognato H
Dystroglycan modulates the ability of insulin-like growth factor-1 to promote oligodendrocyte differentiation.
- DOI:10.1002/jnr.22484
- 发表时间:2010-11-15
- 期刊:
- 影响因子:4.2
- 作者:Galvin, Jason;Eyermann, Christopher;Colognato, Holly
- 通讯作者:Colognato, Holly
Laminin alters fyn regulatory mechanisms and promotes oligodendrocyte development.
- DOI:10.1523/jneurosci.0888-09.2009
- 发表时间:2009-09-23
- 期刊:
- 影响因子:0
- 作者:Relucio J;Tzvetanova ID;Ao W;Lindquist S;Colognato H
- 通讯作者:Colognato H
Glia unglued: how signals from the extracellular matrix regulate the development of myelinating glia.
- DOI:10.1002/dneu.20966
- 发表时间:2011-11
- 期刊:
- 影响因子:3
- 作者:Colognato H;Tzvetanova ID
- 通讯作者:Tzvetanova ID
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
HOLLY A COLOGNATO其他文献
HOLLY A COLOGNATO的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('HOLLY A COLOGNATO', 18)}}的其他基金
Abnormalities in postnatal brain development as a feature of congenital muscular dystrophies
先天性肌营养不良症的一个特征是出生后大脑发育异常
- 批准号:
10293053 - 财政年份:2020
- 资助金额:
$ 36.88万 - 项目类别:
Shared Instrumentation Grant for the purchase of a Leica SP8X Confocal
用于购买 Leica SP8X Confocal 的共享仪器补助金
- 批准号:
9075725 - 财政年份:2016
- 资助金额:
$ 36.88万 - 项目类别:
A 6BETA 1 INTEGRIN-MEDIATED SURVIVAL OF OLIGODENDROCYTES
6BETA 1 整合素介导的少突细胞存活
- 批准号:
6539533 - 财政年份:2002
- 资助金额:
$ 36.88万 - 项目类别:
相似国自然基金
新型F-18标记香豆素衍生物PET探针的研制及靶向Alzheimer's Disease 斑块显像研究
- 批准号:81000622
- 批准年份:2010
- 资助金额:20.0 万元
- 项目类别:青年科学基金项目
阿尔茨海默病(Alzheimer's disease,AD)动物模型构建的分子机理研究
- 批准号:31060293
- 批准年份:2010
- 资助金额:26.0 万元
- 项目类别:地区科学基金项目
跨膜转运蛋白21(TMP21)对引起阿尔茨海默病(Alzheimer'S Disease)的γ分泌酶的作用研究
- 批准号:30960334
- 批准年份:2009
- 资助金额:22.0 万元
- 项目类别:地区科学基金项目
相似海外基金
Pathophysiological mechanisms of hypoperfusion in mouse models of Alzheimer?s disease and small vessel disease
阿尔茨海默病和小血管疾病小鼠模型低灌注的病理生理机制
- 批准号:
10657993 - 财政年份:2023
- 资助金额:
$ 36.88万 - 项目类别:
Social Connectedness and Communication in Parents with Huntington''s Disease and their Offspring: Associations with Psychological and Disease Progression
患有亨廷顿病的父母及其后代的社会联系和沟通:与心理和疾病进展的关联
- 批准号:
10381163 - 财政年份:2022
- 资助金额:
$ 36.88万 - 项目类别:
The Role of Menopause-Driven DNA Damage and Epigenetic Dysregulation in Alzheimer s Disease
更年期驱动的 DNA 损伤和表观遗传失调在阿尔茨海默病中的作用
- 批准号:
10531959 - 财政年份:2022
- 资助金额:
$ 36.88万 - 项目类别:
The Role of Menopause-Driven DNA Damage and Epigenetic Dysregulation in Alzheimer s Disease
更年期驱动的 DNA 损伤和表观遗传失调在阿尔茨海默病中的作用
- 批准号:
10700991 - 财政年份:2022
- 资助金额:
$ 36.88万 - 项目类别:
Interneurons as early drivers of Huntington´s disease progression
中间神经元是亨廷顿病进展的早期驱动因素
- 批准号:
10518582 - 财政年份:2022
- 资助金额:
$ 36.88万 - 项目类别:
Interneurons as Early Drivers of Huntington´s Disease Progression
中间神经元是亨廷顿病进展的早期驱动因素
- 批准号:
10672973 - 财政年份:2022
- 资助金额:
$ 36.88万 - 项目类别:
Social Connectedness and Communication in Parents with Huntington''s Disease and their Offspring: Associations with Psychological and Disease Progression
患有亨廷顿病的父母及其后代的社会联系和沟通:与心理和疾病进展的关联
- 批准号:
10585925 - 财政年份:2022
- 资助金额:
$ 36.88万 - 项目类别:
Oligodendrocyte heterogeneity in Alzheimer' s disease
阿尔茨海默病中的少突胶质细胞异质性
- 批准号:
10180000 - 财政年份:2021
- 资助金额:
$ 36.88万 - 项目类别:
Serum proteome analysis of Alzheimer´s disease in a population-based longitudinal cohort study - the AGES Reykjavik study
基于人群的纵向队列研究中阿尔茨海默病的血清蛋白质组分析 - AGES 雷克雅未克研究
- 批准号:
10049426 - 财政年份:2021
- 资助金额:
$ 36.88万 - 项目类别:
Repurposing drugs for Alzheimer´s disease using a reverse translational approach
使用逆翻译方法重新利用治疗阿尔茨海默病的药物
- 批准号:
10295809 - 财政年份:2021
- 资助金额:
$ 36.88万 - 项目类别:














{{item.name}}会员




